Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Pneumococcal Infections
- Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
- Safety, Tolerability and Immunogenicity of a Novel Inactivated Whole-cell Pneumococcal Vaccine Gamma PN-3.
- A Controlled Human Pneumococcal Infection Model (PIM) Study
- Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients
- Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
- Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)
- Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)
- Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)
- Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
- Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
- Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
- Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels
- Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
- Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
- Aerosolized and Intravenous Colistin in Healthy Adults
- Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
- Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
- 9-valent CRM 197 Pneumococcal